Thermo Fisher, National University of Singapore Ink Life Sciences MOU | GenomeWeb

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific and the National University of Singapore today announced the signing of a memorandum of understanding to develop a strategic alliance to increase advance basic and applied research in Singapore.

The agreement covers the life sciences, healthcare, and applied markets, and includes cancer and diagnostics. Thermo Fisher and NUS will develop analytical technologies, reagents, instruments, and software, they said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.